IGHV3-42: A Potential Drug Target and Biomarker (G28427)

Target Name: IGHV3-42

NCBI ID: G28427

IGHV3-42

Other Name(s): immunoglobulin heavy variable 3-42 (pseudogene) | IGHV342 | Immunoglobulin heavy variable 3-42 (pseudogene) | 3-42P

IGHV3-42: A Potential Drug Target and Biomarker

Immunoglobulin heavy variable 3-42 (IGHV3-42), also known as immunoglobulin heavy variable 3 (IgHV3), is a non-coding RNA molecule that plays a critical role in the regulation of immune responses and inflammation. IGHV3-42 is one of the largest gene products in the human genome, with a length of approximately 21 kilobases (kb) and a gene size of 119 kilobases (kb). The IGHV3-42 gene is located on chromosome 6p21.2 and has been implicated in the development and progression of several diseases, including autoimmune disorders, cancer, and neurodegenerative diseases.

IGHV3-42 is a key regulator of the B cell development and function. During B cell development, IGHV3-42 is transcribed from the DNA template and then translated into a functional antibody molecule by the process of translation. The IGHV3-42 gene has been shown to play a critical role in the regulation of B cell maturation and the production of high-affinity antibody responses.

In addition to its role in B cell development, IGHV3-42 has also been shown to be involved in the regulation of T cell development and function. IGHV3-42 has been shown to be a negative regulator of the T cell receptor (TCR) gene, which is responsible for the development and function of T cells.

IGHV3-42 has also been shown to play a role in the regulation of immune cell function and has been implicated in the development of autoimmune diseases. For example, studies have shown that IGHV3-42 is involved in the regulation of the activity of the immune cell, T cells, and that it plays a role in the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

In addition to its potential role in autoimmune diseases, IGHV3-42 has also been shown to be involved in the regulation of cancer development and progression. For example, studies have shown that IGHV3-42 is involved in the regulation of the development and progression of cancer, and that it plays a role in the regulation of cell cycle progression and apoptosis.

IGHV3-42 has also been shown to be involved in the regulation of neurodegenerative diseases. For example, studies have shown that IGHV3-42 is involved in the regulation of the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In conclusion, IGHV3-42 is a non-coding RNA molecule that plays a critical role in the regulation of immune responses and inflammation. Its role in B, T, and natural killer cell development and function, as well as its involvement in the regulation of autoimmune diseases, cancer, and neurodegenerative diseases makes IGHV3-42 an attractive drug target and biomarker. Further research is needed to fully understand the role of IGHV3-42 in these diseases and to develop effective therapies based on its properties.

Protein Name: Immunoglobulin Heavy Variable 3-42 (pseudogene)

The "IGHV3-42 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHV3-42 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets